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Objective: We present the case of a white man with a facial nodule suspicious for basal
cell carcinoma. Methods: Biopsy revealed clusters of basaloid tumor cells with periph-
eral palisading, consistent with a superﬁcial spreading variant of basal cell carcinoma.
Results: The patient was treated with Mohs micrographic surgery, with clear margins
achieved after the second stage of excision. However, since itwas a superﬁcial spreading
basal cell carcinoma, this was followed by topical imiquimod treatment. Conclusion:
Topical chemotherapy with imiquimod or 5-ﬂuorouracil may be valuable alternatives or
adjuncts, given the increased likelihood of recurrence after surgical excision of superﬁ-
cial spreading basal cell carcinoma. Mohs surgery is of limited value in the management
of superﬁcial spreading basal cell carcinoma because it characteristically shows areas of
uninvolved skin between tumor nests.
Basal cell carcinoma (BCC) is the most common skin cancer in white individuals.1
Similar to other nonmelanoma skin cancers, its incidence is rising. The nodular, superﬁcial
spreading, and inﬁltrating variants are the 3 most commonly encountered types of BCC
in descending order of prevalence.2 Superﬁcial spreading basal cell carcinoma (SSBCC)
accounts for 15% to 26% of all cases of BCC.1 It usually occurs on the trunk and upper
extremities but may be seen on the face.1,3 It appears to be related to acute exposure to
sunlight, especially painful sunburns before the age of 20.4,5
Surgical excision is the most commonly used treatment of BCC.2 Mohs micrographic
surgery is widely used for high-risk head and neck tumors.6 The precise and complete
controlofperipheraltumormarginsthatisachievedusingMohsmicrographicsurgeryyields
highcurerateswithverylowrecurrenceandallowsmaximalpreservationoftissue.7,8 Given
the various phenotypic manifestations of BCC, tailoring the treatment to the appropriate
disease variant optimizes therapeutic success. We report on a case of SSBCC of the face.
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Superﬁcialspreadingbasalcellcarcinomatendstospreadwidelywith“skipareas”inwhich
no tumor is present, compromising the earlier mentioned treatment approaches.
CASE REPORT
A58-year-oldwhitemanwithnosigniﬁcantmedicalhistorypresentedwithapearlynodule
on the dorsum of the nose. A 5-mm punch excisional biopsy was performed with surgical
orientation. Histological analysis of the frozen sections revealed positive margins at 12, 3,
and 6 o’clock positions. Multiple nests of tumor cells were seen budding into the dermis
from the basal cell layer. They were primarily located at the dermal-epidermal junction.
The basaloid tumor cells had hyperchromatic but uniform nuclei and formed a peripheral
palisading pattern. However, cleft-like retraction spaces were not seen between the tumor
nests and mucinous stroma. Such cleft-like spaces, although characteristic of BCC, are
often not seen in SSBCC. The tumor nests spread horizontally. Figures 1 to 3 illustrate
these histological ﬁndings. A diagnosis of SSBCC was made. A second excisional biopsy
was performed, with an additional 2-mm margin taken throughout. Because this was an
SSBCC, surgery was followed by treatment with topical imiquimod.
Figure 1. Superﬁcial spreading basal cell carcinoma. A “skip region” can be seen between
two nests of tumor cells at the dermal-epidermal junction. Solar elastosis is also evident.
(H&E, original magniﬁcation ×10).
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Figure 2. Superﬁcial spreading basal cell carcinoma. A cluster of basaloid tumor cells budding
downward from the basal cell layer, limited to the dermal-epidermal junction, is visible here. It is
ﬂanked on both sides by tumor-free tissue. (H&E, original magniﬁcation ×40).
DISCUSSION
Despite its very high prevalence, BCC is generally a low-grade neoplasm. Although it
can be locally invasive and destructive, it rarely metastasizes and is readily amenable to
excisional management. However, facial BCC is particularly concerning. It is often found
in a cosmetically delicate location. It also has one of the highest recurrence rates of any
BCC. Therefore, appropriate diagnosis and therapy are essential.
Superﬁcial spreading basal cell carcinoma of the face is a surgical challenge due
to its location, the likelihood of recurrence, and its disseminating pattern. Histologically,
SSBCC is characterized by small nests of basaloid cells conﬁned to the epidermis and
superﬁcialdermis,originatingatthedermal-epidermaljunction;thereisahorizontalspread
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usually without deeper dermal involvement.3 Superﬁcial spreading basal cell carcinoma
also has intermittent regions of normal skin, forming classic “skip regions.” It is also
known as “multicentric” or “multifocal” BCC for this reason. Importantly, this unique
characteristicmakesitdifﬁculttoaccuratelyassessthetumorbordersaftersurgicalresection
with negative margins. This may result in incomplete primary tissue excision and can
increase the likelihood of recurrence.9
Figure 3. Superﬁcial spreading basal cell carcinoma. These basaloid tumor cells demonstrate
hyperchromatism with uniform nuclei and peripheral palisading, but cleft-like spaces are not seen
around the nodule. (H&E, original magniﬁcation ×40).
Clinically, SSBCC appears as a red, slightly scaly, and well-demarcated patch. It may
present as a solitary patch or multiple patches. It may appear with the characteristic pearly,
rolled border with a slightly depressed center. It can resemble a patch of dermatitis and
can be confused with eczema, psoriasis, lichen planus, or Bowen’s disease.3,10 Thus, the
clinical features alone may not reveal the appropriate diagnosis. Dermoscopy may assist in
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this endeavor.10 Shiny white to red areas; short, ﬁne telangiectasias; and erosions are the
hallmark dermoscopic features of SSBCC.10
A biopsy is the most reliable diagnostic modality for BCC. Excision is the treatment
of choice for BCC. Mohs micrographic surgery is the therapeutic modality of choice
for primary and high-risk facial BCCs.11 However, because of the nature of SSBCC, the
tumors may be inadequately excised despite clear margins. Deep tissue excision may also
be unnecessary, as the tumor cells are usually very superﬁcial. Topical imiquimod or 5-
ﬂuorouracil may be alternative or adjunct therapies for SSBCC.12−14
CONCLUSION
Superﬁcial spreading basal cell carcinoma may recur despite surgical excision with neg-
ative margins because of its tendency to produce a mosaic pattern of tumor-free regions.
Superﬁcial excision and topical chemotherapy may be preferable in some cases.
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